Literature DB >> 21865131

Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention.

María Sereno1, Cristina Aguayo, Carmen Guillén Ponce, César Gómez-Raposo, Francisco Zambrana, Miriam Gómez-López, Enrique Casado.   

Abstract

Gastric cancer is the major cause of cancer-related deaths worldwide. The majority of them are classified as sporadic, whereas the remaining 10% exhibit familial clustering. Hereditary diffuse gastric cancer (HDGC) syndrome is the most important condition that leads to hereditary gastric cancer. However, other hereditary cancer syndromes, such as hereditary non-polyposis colorectal cancer, familial adenomatous polyposis, Peutz-Jeghers syndrome, Li-Fraumeni syndrome and hereditary breast and ovarian cancer, entail a higher risk compared to the general population for developing this kind of neoplasia. In this review, we describe briefly the most important aspects related to clinical features, molecular biology and strategies for prevention in hereditary gastric associated to different cancer syndromes.

Entities:  

Mesh:

Year:  2011        PMID: 21865131     DOI: 10.1007/s12094-011-0705-y

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  58 in total

1.  Prophylactic surgery prevents endometrial and ovarian cancer in Lynch syndrome.

Authors:  Henry T Lynch; Murray Joseph Casey
Journal:  Nat Clin Pract Oncol       Date:  2007-10-30

Review 2.  Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.

Authors:  Parry Guilford; Bostjan Humar; Vanessa Blair
Journal:  Gastric Cancer       Date:  2010-04-07       Impact factor: 7.370

3.  Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients.

Authors:  P Domizio; I C Talbot; A D Spigelman; C B Williams; R K Phillips
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

4.  Oral contraceptives and polyp regression in familial adenomatous polyposis.

Authors:  Francis M Giardiello; Linda M Hylind; Jill D Trimbath; Stanley R Hamilton; Katharine E Romans; Marcia Cruz-Correa; Mary C Corretti; G Johan A Offerhaus; Vincent W Yang
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

5.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

6.  Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.

Authors:  Marcia S Brose; Timothy R Rebbeck; Kathleen A Calzone; Jill E Stopfer; Katherine L Nathanson; Barbara L Weber
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

7.  Wireless capsule endoscopy for evaluation of phenotypic expression of small-bowel polyps in patients with Peutz-Jeghers syndrome and in symptomatic first-degree relatives.

Authors:  J Soares; L Lopes; G Vilas Boas; C Pinho
Journal:  Endoscopy       Date:  2004-12       Impact factor: 10.093

8.  Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.

Authors:  P C Hebbard; A Macmillan; D Huntsman; P Kaurah; F Carneiro; X Wen; A Kwan; D Boone; F Bursey; J Green; B Fernandez; D Fontaine; D A Wirtzfeld
Journal:  Ann Surg Oncol       Date:  2009-05-01       Impact factor: 5.344

9.  Fundic gland polyp dysplasia is common in familial adenomatous polyposis.

Authors:  Laura K Bianchi; Carol A Burke; Ana E Bennett; Rocio Lopez; Hennie Hasson; James M Church
Journal:  Clin Gastroenterol Hepatol       Date:  2008-02       Impact factor: 11.382

10.  Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli.

Authors:  A Zwick; M Munir; C K Ryan; J Gian; R W Burt; M Leppert; L Spirio; W Y Chey
Journal:  Gastroenterology       Date:  1997-08       Impact factor: 22.682

View more
  11 in total

Review 1.  Advances of Molecular Targeted Therapy in Gastric Cancer.

Authors:  Bulent Cetin; Ozge Gumusay; Mustafa Cengiz; Ahmet Ozet
Journal:  J Gastrointest Cancer       Date:  2016-06

Review 2.  Familial Gastric Cancers.

Authors:  Namrata Setia; Jeffrey W Clark; Dan G Duda; Theodore S Hong; Eunice L Kwak; John T Mullen; Gregory Y Lauwers
Journal:  Oncologist       Date:  2015-09-30

3.  Prophylactic total gastrectomy in the management of hereditary tumor syndromes.

Authors:  Dimitrios Pantelis; Robert Hüneburg; Ronja Adam; Stefanie Holzapfel; Heidrun Gevensleben; Jacob Nattermann; Christian P Strassburg; Stefan Aretz; Jörg C Kalff
Journal:  Int J Colorectal Dis       Date:  2016-09-28       Impact factor: 2.571

4.  Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population.

Authors:  Minkyo Song; M Constanza Camargo; Stephanie J Weinstein; Ana F Best; Satu Männistö; Demetrius Albanes; Charles S Rabkin
Journal:  Gastric Cancer       Date:  2018-02-17       Impact factor: 7.370

Review 5.  Li-Fraumeni syndrome: cancer risk assessment and clinical management.

Authors:  Kate A McBride; Mandy L Ballinger; Emma Killick; Judy Kirk; Martin H N Tattersall; Rosalind A Eeles; David M Thomas; Gillian Mitchell
Journal:  Nat Rev Clin Oncol       Date:  2014-03-18       Impact factor: 66.675

6.  Familial gastric cancer: detection of a hereditary cause helps to understand its etiology.

Authors:  Ingrid P Vogelaar; Rachel S van der Post; Tanya M Bisseling; J Han Jm van Krieken; Marjolijn Jl Ligtenberg; Nicoline Hoogerbrugge
Journal:  Hered Cancer Clin Pract       Date:  2012-12-12       Impact factor: 2.857

Review 7.  Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.

Authors:  Rachel S van der Post; Ingrid P Vogelaar; Fátima Carneiro; Parry Guilford; David Huntsman; Nicoline Hoogerbrugge; Carlos Caldas; Karen E Chelcun Schreiber; Richard H Hardwick; Margreet G E M Ausems; Linda Bardram; Patrick R Benusiglio; Tanya M Bisseling; Vanessa Blair; Eveline Bleiker; Alex Boussioutas; Annemieke Cats; Daniel Coit; Lynn DeGregorio; Joana Figueiredo; James M Ford; Esther Heijkoop; Rosella Hermens; Bostjan Humar; Pardeep Kaurah; Gisella Keller; Jennifer Lai; Marjolijn J L Ligtenberg; Maria O'Donovan; Carla Oliveira; Hugo Pinheiro; Krish Ragunath; Esther Rasenberg; Susan Richardson; Franco Roviello; Hans Schackert; Raquel Seruca; Amy Taylor; Anouk Ter Huurne; Marc Tischkowitz; Sheena Tjon A Joe; Benjamin van Dijck; Nicole C T van Grieken; Richard van Hillegersberg; Johanna W van Sandick; Rianne Vehof; J Han van Krieken; Rebecca C Fitzgerald
Journal:  J Med Genet       Date:  2015-05-15       Impact factor: 6.318

8.  Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.

Authors:  Eleanor Fewings; Alexey Larionov; James Redman; Mae A Goldgraben; James Scarth; Susan Richardson; Carole Brewer; Rosemarie Davidson; Ian Ellis; D Gareth Evans; Dorothy Halliday; Louise Izatt; Peter Marks; Vivienne McConnell; Louis Verbist; Rebecca Mayes; Graeme R Clark; James Hadfield; Suet-Feung Chin; Manuel R Teixeira; Olivier T Giger; Richard Hardwick; Massimiliano di Pietro; Maria O'Donovan; Paul Pharoah; Carlos Caldas; Rebecca C Fitzgerald; Marc Tischkowitz
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-04-27

9.  Clinicopathological significance of NMIIA overexpression in human gastric cancer.

Authors:  Dongning Liu; Lei Zhang; Zhiyong Shen; Fei Tan; Yanfeng Hu; Jiang Yu; Guoxin Li
Journal:  Int J Mol Sci       Date:  2012-11-19       Impact factor: 5.923

10.  Genome-wide association study identifies gastric cancer susceptibility loci at 12q24.11-12 and 20q11.21.

Authors:  Chizu Tanikawa; Yoichiro Kamatani; Osamu Toyoshima; Hiromi Sakamoto; Hidemi Ito; Atsushi Takahashi; Yukihide Momozawa; Makoto Hirata; Nobuo Fuse; Takako Takai-Igarashi; Atsushi Shimizu; Makoto Sasaki; Taiki Yamaji; Norie Sawada; Motoki Iwasaki; Shoichiro Tsugane; Mariko Naito; Asahi Hishida; Kenji Wakai; Norihiro Furusyo; Yoshinori Murakami; Yusuke Nakamura; Issei Imoto; Johji Inazawa; Isao Oze; Naomi Sato; Fumihiko Tanioka; Haruhiko Sugimura; Hiroshi Hirose; Teruhiko Yoshida; Keitaro Matsuo; Michiaki Kubo; Koichi Matsuda
Journal:  Cancer Sci       Date:  2018-10-31       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.